ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

BGJ398 for Patients With Tumors With FGFR Genetic Alterations

ClinicalTrials.gov ID: NCT02160041

Public ClinicalTrials.gov record NCT02160041. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 4:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module 6 - BGJ398 for Patients With Tumors With FGFR Genetic Alterations

Study identification

NCT ID
NCT02160041
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
84 participants

Conditions and interventions

Interventions

  • BGJ398 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 23, 2014
Primary completion
Apr 29, 2018
Completion
Apr 29, 2018
Last update posted
Jun 17, 2019

2014 – 2018

United States locations

U.S. sites
56
U.S. states
30
U.S. cities
52
Facility City State ZIP Site status
Alabama Oncology St. Vincent's Birmingham Birmingham Alabama 35211
North County Oncology Medical Clinic Inc Oceanside California 92056
San Francisco General Hospital San Francisco Gen Hosp (7) San Francisco California 94110
Rocky Mountain Cancer Centers Rocky Mountain Cancer Ctr (50) Greenwood Village Colorado 80304
Norwalk Hospital Norwalk Connecticut 06856
Florida Cancer Specialists Florida Cancer Specialists 36 Fort Myers Florida 33901
University of Miami Sylvester Comprehensive Cancer Miami Florida 33136
NorthWest Georgia Oncology Centers NW Georgia Oncology Marietta Georgia 30060
Harbin Clinic Medical Oncology Clin. Res. Rome Georgia 30165
Illinois Cancer Specialists Arlington Heights Illinois 60005
Lurie Children's Hospital of Chicago Developmental Therapeutics Chicago Illinois 60611
Community Clinical Research Center Anderson Indiana 46011
Indiana University Indiana Univ. - Purdue Univ. Indianapolis Indiana 46202
Northern Indiana Cancer Research Consortium No. Indiana Cancer Res. South Bend Indiana 46617
University of Louisville / James Graham Brown Cancer Center SC Louisville Kentucky 40202
St. Agnes Hospital St. Agnes Hospital (2) Baltimore Maryland 21229
Southcoast Centers for Cancer Care Fairhaven Massachusetts 02719
Cancer and Hematology Centers of West Michigan Dept. of Oncology Grand Rapids Michigan 49546
Minnesota Oncology Hematology, P.A. Minnesota Oncology Hem (27) Minneapolis Minnesota 55404
Research Medical Center Research Med Center (2) Kansas City Missouri 64132
Billings Clinic Billings Clinic (8) Billings Montana 59101
Dartmouth Hitchcock Medical Center Dartmouth Hitchcock - Lebanon Bedford New Hampshire 03110
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903
New Mexico Cancer Center Albuquerque New Mexico 87109
Waverly Hematology Oncology Cary North Carolina 27518
University of N C at Chapel Hill Physician Office Building Chapel Hill North Carolina 27599-7600
Duke University Medical Center Seeley G. Mudd Bldg. Durham North Carolina 27710
Wake Forest Baptist Health Hem & Onc Medical Center Winston-Salem North Carolina 27157
Sanford Hematology Oncology Fargo North Dakota 58122
Oncology Hematology Care Inc Oncology Hematology Care 2 Cincinnati Ohio 45242
University Hospitals of Cleveland Seidman Cancer Center University Hospitals Cleveland Ohio 44106
Cleveland Clinic Foundation Taussig Cancer Institute Cleveland Ohio 44195
Bend Memorial Clinic Bend Mem. Clinic Bend Oregon 97701
Northwest Cancer Specialists Northwest Cancer Portland Oregon 97210
Lehigh Valley Health Network Allentown Pennsylvania 18103
Cancer Treatment Centers of America Eastern Regional Medical Center Philadelphia Pennsylvania 19124
University of Pittsburgh Cancer Institute Hillman Cancer Center (2) Pittsburgh Pennsylvania 15232
Rhode Island Hospital Rhode Island Hosp. (2) Providence Rhode Island 02903
Sanford University of South Dakota Medical Center Sanford Health Sioux Falls South Dakota 57104
Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Oncology Chattanooga Tennessee 37404
Tennessee Oncology Tennessee Oncology (3) Nashville Tennessee 37203
The Center for Cancer and Blood Disorders Fort Worth Texas 76104
Oncology Consultants Oncology Group Houston Texas 77024
Houston Methodist Cancer Center Houston Texas 77030
MD Anderson Cancer Center/University of Texas MD Anderson Cancer Center (3) Houston Texas 77030
Texas Oncology McAllen Texas 78503
Cancer Therapy & Research Center UT Health Science Center Oncology Dept. San Antonio Texas 78229
Texas Oncology Cancer Care & Research Center Texas Oncology Waco Texas 76712
Deke Slayton Cancer Center Deke Slayton Cancer Center (2) Webster Texas 77598
Intermountain Medical Center Intermountain Healthcare Murray Utah 84157
Northern Utah Cancer Associates Northern Utah Assoc (3) Ogden Utah 84403
University of Utah / Huntsman Cancer Institute SC-2 Salt Lake City Utah 84103
Utah Cancer Specialists Utah Cancer Specialists (11) Salt Lake City Utah 84106
Virginia Cancer Specialists Fairfax Northern Virginia Fairfax Virginia 22031
Shenandoah Oncology Shenandoah Oncology (5) Winchester Virginia 22601
Northwest Medical Specialties NW Medical Specialties Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02160041, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 17, 2019 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02160041 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →